Sanjay Reddy
Appearances
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
- DateMay 19, 2024INTRODUCTION: Per the NCCN guidelines, in general, a patient with clinically staged cT2N0 rectal cancer is recommended to undergo resection upfront…
- DateMay 20, 2024The role of total neoadjuvant therapy (TNT) in pancreatic ductal adenocarcinoma (PDAC) remains controversial with mixed data in the literature…
- DateMay 20, 2024INTRODUCTION: Fragmented Care (FC), care at multiple centers, is an emerging area of study in oncologic care. We examined a cohort of pancreatic cancer patients who received neoadjuvant therapy (NAT) to evaluate if sociodemographic disparities play a predictive role in receiving FC…